Douglas John Karas, Director at Nascent Biotech Inc. (NBIO), bought 60,000 shares at $1.00 ($21K) on 2015-04-03, disclosed to the SEC on 2018-06-11.
Open-market purchase of $21k NBIO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.00 | 10,000 | $10K | 47.6% |
| 2 | $0.22 | 50,000 | $11K | 52.4% |
| Total | $0.35 avg | 60,000 | $21K | 100% |